<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01982734</url>
  </required_header>
  <id_info>
    <org_study_id>051113-HS2</org_study_id>
    <nct_id>NCT01982734</nct_id>
  </id_info>
  <brief_title>Improved Oral Bioavailability of Curcumin Incorporated Into Micelles</brief_title>
  <official_title>Novel Strategies for the Enhancement of the Potency of Nutraceuticals With Low Oral Bioavailability and Their Application in Novel Functional Foods for Optimum Protection of the Aging Brain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Hohenheim</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Federal Ministry of Education and Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Hohenheim</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Curcumin, a lipophilic polyphenol derived from the plant curcuma longa possesses numerous
      health-promoting activities. The oral bioavailability of curcumin is low due to its poor
      aqueous solubility, limited gastrointestinal absorption, rapid metabolism and excretion.
      Therefore, we tested, in a randomized crossover study, simultaneous application of
      phytochemicals and micellar solubilisation, alone and together, as strategies to enhance the
      absorption of curcumin into the body. Furthermore, we investigated age and sex differences in
      curcumin pharmacokinetics.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Area under the plasma concentration versus time curve (AUC) of total curcumin [nmol/L*h]</measure>
    <time_frame>0, 0.5, 1, 2, 4, 6, 8 and 24 h post-dose</time_frame>
    <description>Total curcumin was determined after deconjugation with beta-glucuronidase/sulphatase</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Area under the plasma concentration versus time curve (AUC) of total demethoxycurcumin [nmol/L*h]</measure>
    <time_frame>0, 0.5, 1, 2, 4, 6, 8 and 24 h post-dose</time_frame>
    <description>Total demethoxycurcumin was determined after deconjugation with beta-glucuronidase/sulphatase</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Area under the plasma concentration versus time curve (AUC) of total bisdemethoxycurcumin [nmol/L*h]</measure>
    <time_frame>0, 0.5, 1, 2, 4, 6, 8 and 24 h post-dose</time_frame>
    <description>Total bisdemethoxycurcumin was determined after deconjugation with beta-glucuronidase/sulphatase</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maximum plasma concentration (Cmax) of total curcumin [nmol/L]</measure>
    <time_frame>0, 0.5, 1, 2, 4, 6, 8 and 24 h post-dose</time_frame>
    <description>Total curcumin was determined after deconjugation with beta-glucuronidase/sulphatase</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maximum plasma concentration (Cmax) of total demethoxycurcumin [nmol/L]</measure>
    <time_frame>0, 0.5, 1, 2, 4, 6, 8 and 24 h post-dose</time_frame>
    <description>Total demethoxycurcumin was determined after deconjugation with beta-glucuronidase/sulphatase</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maximum plasma concentration (Cmax) of total bisdemethoxycurcumin [nmol/L]</measure>
    <time_frame>0, 0.5, 1, 2, 4, 6, 8 and 24 h post-dose</time_frame>
    <description>Total bisdemethoxycurcumin was determined after deconjugation with beta-glucuronidase/sulphatase</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to reach maximum plasma concentration (Tmax) of total curcumin [h]</measure>
    <time_frame>0, 0.5, 1, 2, 4, 6, 8 and 24 h post-dose</time_frame>
    <description>Total curcumin was determined after deconjugation with beta-glucuronidase/sulphatase</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to reach maximum plasma concentration (Tmax) of total demethoxycurcumin [h]</measure>
    <time_frame>0, 0.5, 1, 2, 4, 6, 8 and 24 h post-dose</time_frame>
    <description>Total demethoxycurcumin was determined after deconjugation with beta-glucuronidase/sulphatase</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to reach maximum plasma concentration (Tmax) of total bisdemethoxycurcumin [h]</measure>
    <time_frame>0, 0.5, 1, 2, 4, 6, 8 and 24 h post-dose</time_frame>
    <description>Total bisdemethoxycurcumin was determined after deconjugation with beta-glucuronidase/sulphatase</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum aspartate transaminase activity [U/L]</measure>
    <time_frame>0, 4, 24h post-dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum alanine transaminase activity [U/L]</measure>
    <time_frame>0, 4, 24h post-dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum gamma-glutamyl transferase activity [U/L]</measure>
    <time_frame>0, 4, 24h post-dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum alkaline phosphatase activity [U/L]</measure>
    <time_frame>0, 4, 24h post-dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum bilirubin [mg/dL]</measure>
    <time_frame>0, 4, 24h post-dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum uric acid [mg/dL]</measure>
    <time_frame>0, 4, 24h post-dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum creatinine [mg/dL]</measure>
    <time_frame>0, 4, 24h post-dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum total cholesterol [mg/dL]</measure>
    <time_frame>0, 4, 24h post-dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum HDL cholesterol [mg/dL]</measure>
    <time_frame>0, 4, 24h post-dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum LDL cholesterol [mg/dL]</measure>
    <time_frame>0, 4, 24h post-dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum triacylglycerols [mg/dL]</measure>
    <time_frame>0, 4, 24h post-dose</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">23</enrollment>
  <condition>Pharmacokinetics of New Curcumin Formulations</condition>
  <condition>Safety of New Curcumin Formulations</condition>
  <arm_group>
    <arm_group_label>Native curcumin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>80 mg curcumin as native powder</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Native curcumin plus phytochemicals</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>80 mg curcumin as native powder plus 80 mg sesamin, 40 mg naringenin, 40 mg ferulic acid and 40 mg xanthohumol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Curcumin micelles</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>80 mg curcumin incorporated into liquid micelles</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Curcumin micelles plus phytochemicals</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>80 mg curcumin incorporated into liquid micelles plus 80 mg sesamin, 40 mg naringenin, 40 mg ferulic acid, 40 mg xanthohumol incorporated into micelles</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>curcumin</intervention_name>
    <description>80 mg curcumin were given orally either as native powder, native powder plus phytochemicals,micelles or micelles plus phytochemicals</description>
    <arm_group_label>Native curcumin</arm_group_label>
    <arm_group_label>Native curcumin plus phytochemicals</arm_group_label>
    <arm_group_label>Curcumin micelles</arm_group_label>
    <arm_group_label>Curcumin micelles plus phytochemicals</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy volunteers with routine blood chemistry values within the normal ranges

          -  Age: 18-35 years or &gt; 60 years

        Exclusion Criteria:

          -  overweight (BMI &gt;30 kg/m2)

          -  metabolic and endocrine diseases

          -  pregnancy

          -  lactation

          -  drug abuse

          -  use of dietary supplements or any form of medication (with the exception of oral
             contraceptives)

          -  smoking

          -  frequent alcohol consumption (&gt;20 g ethanol/d)

          -  adherence to a restrictive dietary regimen

          -  physical activity of more than 5 h/wk
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Frank, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Hohenheim, Stuttgart, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Hohenheim</name>
      <address>
        <city>Stuttgart</city>
        <state>Baden-Württemberg</state>
        <zip>70599</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.nutrition-research.de/</url>
    <description>Website of the research group</description>
  </link>
  <results_reference>
    <citation>Kocher, A., Schiborr, C., Behnam, D., &amp; Frank, J. (2015). The oral bioavailability of curcuminoids in healthy humans is markedly enhanced by micellar solubilisation but not further improved by simultaneous ingestion of sesamin, ferulic acid, naringenin and xanthohumol. J Funct Foods 14: 183-19.</citation>
  </results_reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 5, 2013</study_first_submitted>
  <study_first_submitted_qc>November 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 13, 2013</study_first_posted>
  <last_update_submitted>October 24, 2016</last_update_submitted>
  <last_update_submitted_qc>October 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>bioavailability</keyword>
  <keyword>curcumin</keyword>
  <keyword>pharmacokinetic</keyword>
  <keyword>curcuma longa</keyword>
  <keyword>age differences</keyword>
  <keyword>sex differences</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Curcumin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

